Julius Knowles

Julius Knowles is currently an Independent Director at Keros Therapeutics, Inc. since 2016.
Holds Director positions at Abcuro, Inc. and Paros Bio, Inc. Serves as Partner at Mass General Brigham Ventures LLC and Partners Innovation Fund LLC since 2014, and at Partners Innovation Fund II LP.
Formerly Chief Executive Officer at X-Body, Inc. from 2012 to 2014.
Served as Director at Aurigene Oncology Ltd. and Rome Therapeutics, Inc. Was Director-Research & Development Planning at Vertex Pharmaceuticals, Inc. from 1993 to 1999.
Head-Strategic Alliances at Novartis Institutes for Biomedical Research, Inc. from 2006 to 2012.
President of Novalar Pharmaceuticals, Inc. from 2002 to 2006.
Vice President-Business Development at SGX Pharmaceuticals, Inc. from 1999 to 2001 and at Novacea, Inc. from 2001 to 2002.
Education includes an MBA from the University of Pennsylvania in 1993, graduate studies at the University of California, Berkeley in 1987, and an undergraduate degree from Carleton College in 1985.